Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Search content at Experts@Minnesota
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Giant cell tumour of bone
David M. Thomas
,
Keith M. Skubitz
Medicine - Hematology, Oncology, Transplant
Cellular Mechanisms of Cancer
Research output
:
Contribution to journal
›
Review article
›
peer-review
140
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Giant cell tumour of bone'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Giant Cell Tumor of Bone
100%
Denosumab
50%
Clinical Trials
16%
Bone Disease
16%
Hypoxia
16%
Monoclonal Antibody
16%
Treatment Options
16%
Angiogenesis
16%
Targets for Therapy
16%
Young Population
16%
Clinical Benefit
16%
Targeted Agents
16%
% Response
16%
New Treatment Options
16%
Benign Bone Tumor
16%
Osteoclast Differentiation Factor
16%
Receptor Activator of nuclear factor-κB Ligand (RANKL)
16%
Related Disorders
16%
Comparable Evidence
16%
Colony-stimulating Factor 1 Receptor (CSF1R)
16%
Well Tolerated
16%
Unresectable Disease
16%
Medicine and Dentistry
Osteoclastoma
100%
Osteoclast Differentiation Factor
50%
Denosumab
50%
Treatment Option
33%
Clinical Trial
16%
Hypoxia
16%
Receptor
16%
Human Monoclonal Antibody
16%
Colony Stimulating Factor 1
16%
Angiogenesis
16%
Benign Bone Tumor
16%
Receptor Activator of Nuclear Factor Kappa B
16%
Diseases
16%